Product Information
ABACAVIR 300 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6012 per EA under NDC 65862007360. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862007360
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ABACAVIR SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA077844On Market Since
12/17/2012
Pharmacological Classes
Price Statistics
The NADAC for ABACAVIR 300 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 87.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6012 per EA |
|---|---|
| All-time high | $6.1332 (Feb 12, 2014) |
| All-time low | $0.4392 (Dec 22, 2021) |
| 52-week high | $0.6820 |
| 52-week low | $0.6012 |
| Median price | $0.7952 |
| Average price | $1.6347 |
| Largest weekly change | +59.4% (Feb 23, 2022) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ABACAVIR 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ABACAVIR 300 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6012 per EA (NDC 65862007360), effective Jun 24, 2026.
How has the price of ABACAVIR 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ABACAVIR 300 MG TABLET has declined 87.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ABACAVIR 300 MG TABLET?
Since Nov 28, 2013, the NADAC for ABACAVIR 300 MG TABLET has ranged from a low of $0.4392 (Dec 22, 2021) to a high of $6.1332 (Feb 12, 2014), with a median of $0.7952 per EA.
Are there cheaper alternatives to ABACAVIR 300 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as ABACAVIR 300 MG TABLET, but none are currently priced below it.
Who manufactures ABACAVIR 300 MG TABLET?
ABACAVIR 300 MG TABLET (NDC 65862007360) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification